Infants born into a digital world: Are there developmental inequities based on exposure?
Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, highlights the April 2024 issue of Contemporary Pediatrics.
Food Insecurity and the Dangers of Infant Formula Dilution
First radioactive drug approved for patients 12 years and up with SSTR-positive GEP-NETs
The FDA has approved lutetium Lu 177 dotatate for pediatric patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors.
Demystifying Infant Formula
CRL issued for pz-cel as potential recessive dystrophic epidermolysis bullosa treatment
Abeona's pz-cel is up for indicated use to treat patients with recessive dystrophic epidermolysis bullosa.
Pandemic's impact on early childhood development may have been minimal
An assessment into development scores before, during and after the COVID-19 pandemic show children aged 0 - 5 years old may only had been minimally impacted in communication and problem-solving skills.